Background: Cinchonine is one of the Cinchona alkaloids that is commercially extracted from the Peruvian bark of Cinchona officinalis L. (Family: Rubiaceae). It is also obtained in much lower quantities from other species of Cinchona, such as Cinchona calisaya, Cinchona succirubra, and Cinchona pubescens, and in some other plants, such as Remijia peruviana. Cinchonine has been historically used as an anti-malarial agent. It also has a wide range of other biological properties, including anti-cancer, anti-obesity, anti-inflammatory, anti-parasitic, antimicrobial, anti-platelet aggregation, and anti-osteoclast differentiation.
Aim And Objective: This review discusses the pharmacological activity of cinchonine under different experimental conditions, including , , and . It also covers the compound's physicochemical properties, toxicological aspects, and pharmacokinetics.
Methodology: A comprehensive literature search was conducted on multiple online databases, such as PubMed, Scopus, and Google Scholar. The aim was to retrieve a wide range of review/research papers and bibliographic sources. The process involved applying exclusion and inclusion criteria to ensure the selection of relevant and high-quality papers.
Results: Cinchonine has numerous pharmacological properties, making it a promising compound for various therapeutic applications. It induces anti-cancer activity by activating caspase-3 and PARP-1, and triggers the endoplasmic reticulum stress response. It up-regulates GRP78 and promotes the phosphorylation of PERK and ETIF-2α. Cinchonine also inhibits osteoclastogenesis, inhibiting TAK1 activation and suppressing NFATc1 expression by regulating AP-1 and NF-κB. Its potential anti-inflammatory effects reduce the impact of high-fat diets, making it suitable for targeting obesity-related diseases. However, research on cinchonine is limited, and further studies are needed to fully understand its therapeutic potential. Further investigation is needed to ensure its safety and efficacy in clinical applications.
Conclusion: Overall, this review article explains the pharmacological activity of cinchonine, its synthesis, and physicochemical properties, toxicological aspects, and pharmacokinetics.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/0115680266270796231109171808 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The interaction of cinchonine and immunoglobulin G and the development of a nanocomplex with improved anti-breast cancer activity.
Int J Biol Macromol
January 2025
Department of Ultrasonic Diagnosis, The First Hospital of China Medical University, Shenyang 110001, China. Electronic address:
In this study we evaluated the interaction of cinchonine (Cin) and immunoglobulin G (IgG). Then, Cin-IgG nanoparticles (NPs) were synthesized and characterized. Finally, the anticancer effects of free Cin and Cin-IgG NPs on MCF-7 breast cancer (BC) cells were evaluated.
View Article and Find Full Text PDFSynthesis of Novel Pseudo-Enantiomeric Phase-Transfer Catalysts from Cinchona Alkaloids and Application to the Hydrolytic Dynamic Kinetic Resolution of Racemic 3-Phenyl-2-oxetanone.
Chem Pharm Bull (Tokyo)
October 2024
Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts.
Naturally occurring Cinchona alkaloids such as quinidine (QD)/cinchonine (CN) and their diastereomers, quinine (QN)/cinchonidine (CD), have been recognized as pseudo-enantiomeric pairs. Utilizing these pseudo-enantiomeric alkaloids as chiral resources provides complementary enantioselectivity in many asymmetric reactions. During the screening of Cinchona alkaloid phase-transfer catalysts (PTCs) in the hydrolytic dynamic kinetic resolution of racemic 3-phenyl-2-oxetanone (1) to tropic acid (2), we found that the introduction of a 4-trifluoromethylphenyl group at the vinyl terminus of BnQN significantly reduced the enantioselectivity to 41% enantiomeric excess (ee).
View Article and Find Full Text PDFCCH-Pd complex anchored on ZrFeO nanoparticles as a novel magnetic catalytic for C-C coupling reactions.
Heliyon
September 2024
Student Research Committee, School of Public Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
In the present work, Palladium nanoparticles were supported on Cinchonine functionalized ZrFeO MNPs. The structure, morphology, and physicochemical properties of the particles were characterized through different analytical techniques, including fourier transformed infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), inductively coupled plasma (ICP), X-ray powder diffraction (XRD), thermogravimetric analysis (TGA), energy dispersive X-ray spectroscopy (EDS) and vibrating sample magnetometer (VSM) techniques. Moreover, it was obtained as an efficient catalyst for Hiyama and Suzuki reactions under green conditions with good to excellent yields.
View Article and Find Full Text PDFTwo-Dimensional Correlation Spectroscopy (2D-COS) Tracking of the Formation of Selected Transition Metal Compounds Cu(II) and Cd(II) With Cinchonine and Their Impact on Model Components of Erythrocytes.
Appl Spectrosc
September 2024
Faculty of Chemistry, Jagiellonian University, Kraków, Poland.
Cinchonine is a quinoline alkaloid known for its antimalarial properties. Due to the advantages of using compounds of metal ions with alkaloids, a copper(II) compound with cinchonine was synthesized, and, for comparative purposes, a cadmium(II) compound with cinchonine. During the synthesis, the emerging interactions between the metal ion and cinchonine were studied.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!